InstalabLymphocyte MAP™
Should you take a Lymphocyte MAP™ test?
This test is most useful if any of these apply to you.
35 biomarkers included
- WBC CountThe total count of white blood cells (WBC), the infection-fighting cells that form the backdrop for every subset here.A high or low total signals active infection, inflammation, or marrow issues worth exploring before reading subsets.
- Lymphocyte CountThe absolute number of lymphocytes, the white cells this panel dissects into its specialized squads.A low count (lymphopenia) is the broad flag that prompts the detailed subset breakdown that follows.
- Lymphocytes %The share of your white cells that are lymphocytes, showing how the immune workload is distributed.A shifted proportion points to whether infection, stress, or an immune disorder is reshaping the white-cell mix.
- T Cells (CD3+)The count of T cells, the coordinators and killers at the core of adaptive immunity (CD3 is their shared surface tag).A markedly low T-cell number is the single clearest clue toward a serious immune deficiency.
- T Cells % of Lymphocytes (CD3+)The proportion of lymphocytes that are T cells, showing whether the adaptive arm dominates the pool as expected.An unusually low percentage suggests another cell line has expanded or T cells were selectively lost.
- Helper T Cells (CD4+)The count of helper T cells that direct the rest of the immune response (marked CD4).A low helper count is the marker most tied to infection susceptibility and reduced immune reserve.
- Helper T Cells % of Lymphocytes (CD4+)The share of lymphocytes that are helper T cells, capturing how the command structure is proportioned.A falling helper percentage often accompanies the aging or exhaustion patterns this panel is built to catch.
- Cytotoxic T Cells (CD8+)The count of cytotoxic T cells that directly kill infected and abnormal cells (marked CD8).A high killer count often reflects an active or lingering response to a chronic virus.
- Cytotoxic T Cells % of Lymphocytes (CD8+)The proportion of lymphocytes that are killer T cells, showing how far the balance tilts toward direct attack.A rising killer percentage is a common feature of chronic viral exposure and immune aging.
- CD4:CD8 RatioThe balance between helper and killer T cells, one of immunology's most studied summaries of immune status.A low ratio is used as a marker of immune aging and chronic immune activation.
- T Cell/B Cell ratioThe balance between the T-cell (cellular) and B-cell (antibody) arms of adaptive immunity.A skew signals whether one adaptive arm has expanded or contracted relative to the other.
- B Cells (CD19+)The count of B cells, the antibody-producing arm of your defenses (marked CD19).A low B-cell number can underlie poor antibody responses and repeated bacterial infections.
- B Cells % of Lymphocytes (CD19+)The share of lymphocytes that are B cells, showing the antibody arm's footprint in the pool.A reduced proportion helps distinguish antibody-side problems from T-cell or killer-cell ones.
- Total T-Helper-1 CellThe count of helper cells that drive inflammation to clear viruses and bacteria.An expanded Th1 population reflects an inflammation-forward tilt that emerging research links to autoimmune activity.
- % T-Helper-1 CellThe proportion of helper cells committed to the inflammatory Th1 program.A high Th1 share marks skewing toward cellular inflammation rather than antibody or regulatory responses.
- Total T-Helper-2 CellThe count of helper cells that support antibody and allergic-type responses.An elevated Th2 population is associated with allergic and antibody-driven immune skewing.
- % T-Helper-2 CellThe proportion of helpers committed to the Th2 program that governs allergy and antibody help.A high Th2 share indicates the balance has tilted away from inflammatory Th1 activity.
- Th1/Th2 ratioThe balance between inflammatory (Th1) and allergic or antibody (Th2) helper programs.This ratio summarizes which style of immune response your helper cells currently favor.
- Total T-Helper-17 (Th17) CellThe count of a potent pro-inflammatory helper subset central to fighting certain microbes.An expanded Th17 population is repeatedly associated with autoimmune inflammation in human studies.
- % T-Helper-17 (Th17) CellThe proportion of helpers committed to the inflammatory Th17 program.A high Th17 share, especially against low Tregs, marks an inflammation-tilted balance studied in autoimmunity.
- Total Regulatory T Cell (Treg)The count of regulatory T cells, the brakes that enforce tolerance and restrain inflammation.A low regulatory count signals weakened immune restraint, a pattern emerging research ties to autoimmune activity.
- % Regulatory T Cell (Treg)The share of helper cells serving as regulatory brakes within the pool.A falling regulatory percentage points to reduced restraint even when total counts look adequate.
- Th17/Treg ratioThe balance between inflammatory Th17 cells and regulatory Tregs, the panel's clearest read on immune restraint.A high ratio is the functional-subset pattern most consistently associated with disease activity in autoimmune studies.
- Total NK Cell (CD56+)The count of natural killer cells, fast innate defenders against infected and abnormal cells (marked CD56).A low count can point to reduced innate surveillance; a high count often follows chronic immune activation.
- % NK Cell (CD56+)The proportion of lymphocytes that are natural killers, showing the innate arm's presence in the pool.Natural killer percentage tends to rise with age, reshaping what counts as normal over time.
- Total Cytotoxic NK Cell (CD16+)The count of natural killers carrying CD16, the subset equipped for direct antibody-guided killing.This population reflects your innate capacity to destroy antibody-tagged infected or abnormal cells.
- % Cytotoxic NK Cell (CD16+)The share of natural killer cells in the mature, kill-ready CD16 state.A shift here separates active cytotoxic killers from the regulatory, signal-producing natural killer subset.
- Total NKT Cell (CD56+ CD16+ T Cell)The count of hybrid NKT cells that carry both T-cell and natural killer features, bridging adaptive and innate immunity.Altered NKT numbers appear across various immune-dysregulation states as a bridge-cell signal.
- % NKT Cell (CD56+ CD16+ T Cell)The proportion of lymphocytes that are bridging NKT cells.This share reflects the size of the hybrid population linking rapid innate and targeted adaptive responses.
- Total CD57+ CD16+ NK CellThe count of mature, highly experienced natural killers marked by CD57.An expanded population reflects an innate compartment shaped by long-term viral exposure such as cytomegalovirus.
- % CD57+ CD16+ NK CellThe proportion of natural killer cells in the experienced CD57 state.A high share is a research marker of an innate compartment remodeled by chronic viral experience.
- Total CD3- CD57+ LymphocyteThe count of non-T lymphocytes carrying CD57, a marker of long-differentiated cells.Expansions are studied in chronic infection and immune activation, but are not a stand-alone diagnosis.
- % CD3- CD57+ LymphocyteThe share of lymphocytes that are CD57-positive non-T cells.This proportion is an exploratory readout of accumulated immune experience outside the T-cell line.
- Total CD57+ CD8+ T CellThe count of killer T cells carrying CD57, a hallmark of late-differentiated, battle-experienced cells.In research, expansion reflects cumulative viral exposure and immune aging rather than active illness.
- % CD57+ CD8+ T CellThe share of killer T cells in the experienced CD57 state.A high proportion tracks with cytomegalovirus exposure and immunological age, not chronological age alone.
About Lymphocyte MAP™
A routine blood count tells you how many immune cells are circulating, and then it stops. This panel takes the lymphocytes, the white cells that run your adaptive defenses, and sorts them into the specific squads that fight infection, restrain inflammation, and remember old threats.
That sorting is where the useful signal lives. Two people can have identical lymphocyte counts and very different immune systems underneath, one balanced, one tilted toward inflammation or worn down by decades of viral exposure. This map shows which.
What This Panel Reveals
The foundation is a census of the major players. It counts your T cells (the coordinators and killers of adaptive immunity, marked by a surface tag called CD3), your B cells (the antibody factories, tagged CD19), and your natural killer cells (fast innate defenders, tagged CD56). Getting these three populations in one draw is the standard first step when an immune deficiency is suspected; in one center, this kind of flow-cytometry workup helped diagnose or classify immune disorders in 514 of 670 evaluated patients.
Within the T cells, the panel separates helpers (tagged CD4) from cytotoxic killers (tagged CD8) and reports their ratio. In one healthy adult population, representative values landed near 787 helper cells and 479 killer cells per microliter, with a helper-to-killer ratio around 1.81, but these numbers vary substantially by ethnicity, age, and sex, and every lab sets its own range. That ratio is one of the most studied numbers in immunology and is used as a marker of immune aging, tending to fall as the system accumulates experience and wear.
The panel then profiles the helper T cells by job. Some drive inflammation to clear viruses and bacteria (Th1 and Th17 cells). Others support antibody and allergic responses (Th2 cells). Regulatory T cells (Tregs) act as the brakes, holding the whole system in check. Emerging research links the balance between the inflammatory and regulatory groups to autoimmune activity; in children with type 1 diabetes, for example, a higher ratio of regulatory to inflammatory helper cells has tracked with lower blood sugar and lower insulin needs, though standardized interpretation is still developing.
Finally it looks at the innate and experienced compartments: natural killer subsets, hybrid NKT cells that bridge both arms of immunity, and cells carrying a marker called CD57. In research settings, CD57 tends to appear on immune cells that have been through many rounds of battle, especially against long-lived viruses.
How to Read Your Results Together
No single number here means much alone. The value is in the patterns across the panel, and the table below shows a few worth recognizing.
| Pattern | What It May Suggest |
|---|---|
| Low helper-to-killer ratio with high CD8 | A pattern linked to immune aging or chronic viral exposure; worth pairing with a cytomegalovirus test. |
| Low T, B, and natural killer counts together | A broad shortfall in cell lines, the classic reason to investigate for an immune deficiency. |
| High Th17 with low Tregs | An inflammation-tilted balance that emerging research associates with autoimmune activity. |
| High CD57 on killer T cells | Often reflects long-term viral experience rather than illness; read it with viral history, not in isolation. |
Absolute counts and percentages tell different stories, and both are here for a reason. A count is your reserve, the actual number of cells. A percentage is the distribution, how the pool is divided. A normal percentage can hide a low count, which is why the panel reports both.
What to Do with Your Results
Start with the big three. If your T, B, or natural killer counts fall clearly below the lab's range, especially alongside frequent or severe infections, that warrants a conversation with an immunologist and usually a repeat draw to confirm. Antibody (immunoglobulin) levels are the standard companion test. The point of a low count is real: after moderate COVID-19, a subgroup of recovered adults kept a hidden shortfall in B cells, helper cells, and regulatory cells months later, in 7.3% of moderate and 12.5% of severe cases, that a plain lymphocyte count would have missed.
If the interesting signal is in the balance ratios or the CD57 markers, treat it as a starting map rather than a diagnosis. A cytomegalovirus antibody test clarifies whether a shifted ratio or expanded CD57 population reflects past viral exposure. The ratio is worth attention, though its predictive weight is debated: in people with treated HIV, a helper-to-killer ratio below 0.5 was linked in one meta-analysis to roughly 3.65 times the risk of death from non-AIDS causes, but the largest cohort studies found little added predictive value after accounting for other factors, so the association is not settled. A ratio at or below 0.4 sustained over time predicted more serious clinical events in one cohort. Because these subsets drift with illness and timing, retesting in about three months, when you are well, tells you whether a finding is stable or a passing response.
When Results Can Be Misleading
Almost everything in this panel moves with your current state. A recent infection can pull T-cell counts down for days to a couple of weeks before they rebound. Acute stress, hard exercise, and time of day shift the numbers too. Some subsets are steady from draw to draw while others swing widely: measured repeatedly in healthy adults, within-person variation ranged from 4.23% to 47.47% depending on the subset.
Two background factors matter most. Age reshapes the whole panel, as naive cells fall and experienced cells rise over the decades, so normal for a 30-year-old differs from normal at 70. And past cytomegalovirus infection, extremely common and usually silent, permanently inflates several of the experienced and CD57 populations. Those markers track immune experience and viral history, not your age on paper, so a result read without that context is easy to misjudge.